CollPlant is a regenerative and aesthetic medicine company developing innovative technologies and products for tissue regeneration and organ manufacturing.
Collplant raises a $4,500,000 venture round.
Collplant raises a $5,500,000 venture round.
Collplant raises a $5,000,000 venture round.
Collplant raises a $1,000,000 venture round.
Collplant raises a $7,400,000 venture round from Ami Sagi and Meitav Investment House.
August 12, 2004
Collplant was founded by Oded Shoseyov.
Documentaries, videos and podcasts
June 4, 2021
/PRNewswire/ -- CollPlant (NASDAQ: CLGN), a regenerative and aesthetic medicine company, announced today the uplisting of its ordinary shares to the Nasdaq...
March 4, 2021
/PRNewswire/ -- CollPlant (NASDAQ: CLGN), a regenerative and aesthetics medicine company, today announced that Mr. Yehiel Tal, Chief Executive Officer of...
February 25, 2021
/PRNewswire/ -- CollPlant Biotechnologies (NASDAQ: CLGN) a regenerative and aesthetics medicine company, today announced that on February 24, 2021 it received...